FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Michael Buchanan

Research Profile

Living Beings

Rabbits

Chemicals & Drugs

Anatomy

Physiology

Concepts & Ideas

Co-author Network

Publications

TOP 3
stephanie brister; Michael Buchanan
Aspirin "resistance" and its impact on cardiovascular morbidity and mortality: it is real, clinically relevant and should be measured.
Michael Buchanan
Acetylsalicylic acid resistance and clinical outcome--the Hobikoglu study is worth noting.
Joanne van Ryn; Martin Lorenz; Herbert Merk; Michael Buchanan; Wolfgang G Eisert
Accumulation of radiolabelled platelets and fibrin on the carotid artery of rabbits after angioplasty: effects of heparin and dipyridamole.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Michael Buchanan (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2009: stephanie brister; Michael Buchanan
Aspirin "resistance" and its impact on cardiovascular morbidity and mortality: it is real, clinically relevant and should be measured.
Heart (British Cardiac Society) 2009;95(15):1223-4.
2007: Michael Buchanan
Acetylsalicylic acid resistance and clinical outcome--the Hobikoglu study is worth noting.
The Canadian journal of cardiology 2007;23(3):207-8.
2003: Joanne van Ryn; Martin Lorenz; Herbert Merk; Michael Buchanan; Wolfgang G Eisert
Accumulation of radiolabelled platelets and fibrin on the carotid artery of rabbits after angioplasty: effects of heparin and dipyridamole.
Thrombosis and haemostasis 2003;90(6):1179-86.
1998: S Cortelazzo; M Marchetti; E Orlando; A Falanga; Tiziano Barbui; Michael Buchanan
Aspirin increases the bleeding side effects in essential thrombocythemia independent of the cyclooxygenase pathway: role of the lipoxygenase pathway.
American journal of hematology 1998;57(4):277-82.
1997: Ana Giménez-Arnau; Carlos Barranco; M Alberola; C Wale; S Serrano; Michael Buchanan; JG Camarasa
Effects of linoleic acid supplements on atopic dermatitis.
Advances in experimental medicine and biology 1997;433():285-9.
1996: AM Low; M Berdik; L Sormaz; S Gataiance; Michael Buchanan; Chiu-Yin Kwan; Edwin E Daniel
Plant alkaloids, tetrandrine and hernandezine, inhibit calcium-depletion stimulated calcium entry in human and bovine endothelial cells.
Life sciences 1996;58(25):2327-35.
1995: stephanie brister; Michael Buchanan
Heparinless cardiopulmonary bypass revisited: a newer strategy to avoid heparin-related bleeding using dermatan sulfate.
Journal of cardiothoracic and vascular anesthesia 1995;9(3):317-21.
1993: J Van Ryn-McKenna; H Merk; TH Müller; Michael Buchanan; W G Eisert
The effects of heparin and annexin V on fibrin accretion after injury in the jugular veins of rabbits.
Thrombosis and haemostasis 1993;69(3):227-30.
1993: Michael Buchanan; stephanie brister
Altering vessel wall fatty acid metabolism: a new strategy for antithrombotic treatment.
Seminars in thrombosis and hemostasis 1993;19(2):149-57.
1988: Yaacov Matzner; M Cohn; E Hyam; Ehud Razin; Z Fuks; Michael Buchanan; T A Haas; Israel Vlodavsky; Amiram Eldor
Generation of lipid neutrophil chemoattractant by irradiated bovine aortic endothelial cells.
Journal of immunology (Baltimore, Md. : 1950) 1988;140(8):2681-5.
1987: Frederick A Ofosu; G J Modi; Morris A Blajchman; Michael Buchanan; E A Johnson
Increased sulphation improves the anticoagulant activities of heparan sulphate and dermatan sulphate.
The Biochemical journal 1987;248(3):889-96.
1987: Bernard Boneu; Michael Buchanan; C Caranobe; A M Gabaig; Dominique Dupouy; P Sie; J Hirsh
The disappearance of a low molecular weight heparin fraction (CY 216) differs from standard heparin in rabbits.
Thrombosis research 1987;46(6):845-53.
1987: Bernard Boneu; C Caranobe; A M Gabaig; Dominique Dupouy; P Sie; Michael Buchanan; J Hirsh
Evidence for a saturable mechanism of disappearance of standard heparin in rabbits.
Thrombosis research 1987;46(6):835-44.
1987: Michael Buchanan; R W Butt; A G Turpie
Effect of nafazatrom on platelet function and release: relationship to symptomatic episodes in patients with peripheral vascular disease.
American heart journal 1987;113(5):1133-7.
1987: Frederick A Ofosu; P Sie; G J Modi; F Fernandez; Michael Buchanan; M A Blajchman; B Boneu; J Hirsh
The inhibition of thrombin-dependent positive-feedback reactions is critical to the expression of the anticoagulant effect of heparin.
The Biochemical journal 1987;243(2):579-88.
1987: B E Gibson; Michael Buchanan; R D Barr; J G White
Primary thrombocythaemia in childhood: symptomatic episodes and their relationship to thromboxane A2, 6-keto-PGE1 and 12-hydroxy-eicosatetraenoic acid production: a case report.
Prostaglandins, leukotrienes, and medicine 1987;26(3):221-31.
1986: P Sie; Frederick A Ofosu; F Fernandez; Michael Buchanan; M Petitou; B Boneu
Respective role of antithrombin III and heparin cofactor II in the in vitro anticoagulant effect of heparin and of various sulphated polysaccharides.
British journal of haematology 1986;64(4):707-14.
1986: Michael Buchanan; Frederick A Ofosu; F Fernandez; J Van Ryn
Lack of relationship between enhanced bleeding induced by heparin and other sulfated polysaccharides and enhanced catalysis of thrombin inhibition.
Seminars in thrombosis and hemostasis 1986;12(4):324-7.
1986: F Fernandez; J Van Ryn; Frederick A Ofosu; J Hirsh; Michael Buchanan
The haemorrhagic and antithrombotic effects of dermatan sulphate.
British journal of haematology 1986;64(2):309-17.
1986: C Caranobe; Maurice Petitou; Dominique Dupouy; A M Gabaig; Pierre Sié; Michael Buchanan; Bernard Boneu
Heparin fractions with high and low affinities to antithrombin III are cleared at different rates.
Thrombosis research 1986;43(6):635-41.
1986: F Fernandez; P N'guyen; J Van Ryn; Frederick A Ofosu; J Hirsh; Michael Buchanan
Hemorrhagic doses of heparin and other glycosaminoglycans induce a platelet defect.
Thrombosis research 1986;43(4):491-5.
1986: M Andrew; Frederick A Ofosu; F Fernandez; A Jefferies; J Hirsh; L Mitchell; Michael Buchanan
A low molecular weight heparin alters the fetal coagulation system in the pregnant sheep.
Thrombosis and haemostasis 1986;55(3):342-6.
1986: Michael Buchanan; R W Butt; J Hirsh; B A Markham; D J Nazir
Role of lipoxygenase metabolism in platelet function: effect of aspirin and salicylate.
Prostaglandins, leukotrienes, and medicine 1986;21(2):157-68.
1986: Michael Buchanan; J Hirsh
Effect of aspirin on hemostasis and thrombosis.
New England and regional allergy proceedings 1986;7(1):26-31.
1986: Frederick A Ofosu; G J Modi; J Hirsh; Michael Buchanan; M A Blajchman
Mechanisms for inhibition of the generation of thrombin activity by sulfated polysaccharides.
Annals of the New York Academy of Sciences 1986;485():41-55.
1985: Michael Buchanan; T A Haas; M Lagarde; M Guichardant
13-Hydroxyoctadecadienoic acid is the vessel wall chemorepellant factor, LOX.
The Journal of biological chemistry 1985;260(30):16056-9.
1985: G Agnelli; Michael Buchanan; F Fernandez; J Hirsh
The thrombolytic and hemorrhagic effects of tissue type plasminogen activator: influence of dosage regimens in rabbits.
Thrombosis research 1985;40(6):769-77.
1985: B Boneu; Michael Buchanan; J F Cade; J Van Ryn; F F Fernandez; Frederick A Ofosu; J Hirsh
Effects of heparin, its low molecular weight fractions and other glycosaminoglycans on thrombus growth in vivo.
Thrombosis research 1985;40(1):81-9.
1985: G Agnelli; Michael Buchanan; F Fernandez; J Van Ryn; J Hirsh
Sustained thrombolysis with DNA-recombinant tissue type plasminogen activator in rabbits.
Blood 1985;66(2):399-401.
1985: Frederick A Ofosu; M A Blajchman; G J Modi; L M Smith; Michael Buchanan; J Hirsh
The importance of thrombin inhibition for the expression of the anticoagulant activities of heparin, dermatan sulphate, low molecular weight heparin and pentosan polysulphate.
British journal of haematology 1985;60(4):695-704.
1985: G Agnelli; Michael Buchanan; F Fernandez; B Boneu; J Van Ryn; J Hirsh; D Collen
A comparison of the thrombolytic and hemorrhagic effects of tissue-type plasminogen activator and streptokinase in rabbits.
Circulation 1985;72(1):178-82.
1985: Michael Buchanan; R W Butt; Z Magas; J van Ryn; J Hirsh; D J Nazir
Endothelial cells produce a lipoxygenase derived chemo-repellent which influences platelet/endothelial cell interactions--effect of aspirin and salicylate.
Thrombosis and haemostasis 1985;53(3):306-11.
1985: M Richardson; M W Hatton; Michael Buchanan; S Moore
Scanning electron microscopy of normal rabbit aorta: injury or artifact?
Journal of ultrastructure research 1985;91(2):159-73.
1985: Frederick A Ofosu; F Fernandez; D Gauthier; Michael Buchanan
Heparin cofactor II and other endogenous factors in the mediation of the antithrombotic and anticoagulant effects of heparin and dermatan sulfate.
Seminars in thrombosis and hemostasis 1985;11(2):133-7.
1985: M Andrew; B Boneu; J Cade; A L Cerskus; J Hirsh; A Jefferies; M E Towell; Michael Buchanan
Placental transport of low molecular weight heparin in the pregnant sheep.
British journal of haematology 1985;59(1):103-8.
1985: Michael Buchanan; B Boneu; Frederick A Ofosu; J Hirsh
The relative importance of thrombin inhibition and factor Xa inhibition to the antithrombotic effects of heparin.
Blood 1985;65(1):198-201.
1984: J F Cade; Michael Buchanan; B Boneu; P Ockelford; C J Cater; A L Cerskus; J Hirsh
A comparison of the antithrombotic and haemorrhagic effects of low molecular weight heparin fractions: the influence of the method of preparation.
Thrombosis research 1984;35(6):613-25.
1984: Michael Buchanan; J Hirsh
Effect of aspirin and salicylate on platelet-vessel wall interactions in rabbits.
Arteriosclerosis (Dallas, Tex.) 1984;4(4):403-6.
1983: Michael Buchanan; M J Vazquez; M A Gimbrone
Arachidonic acid metabolism and the adhesion of human polymorphonuclear leukocytes to cultured vascular endothelial cells.
Blood 1983;62(4):889-95.
1983: R W Butt; Michael Buchanan
Basal 6 keto PGF1 alpha levels: influence of sampling techniques.
Thrombosis research 1983;29(4):469-70.
1983: Michael Buchanan; J A Rischke; R Butt; A G Turpie; J Hirsh; J Rosenfeld
The sex-related differences in aspirin pharmacokinetics in rabbits and man and its relationship to antiplatelet effects.
Thrombosis research 1983;29(2):125-39.
1983: Michael Buchanan; L Endrenyi; A R Giles; J Rosenfeld
The effect of aspirin on the pharmacokinetics of sulfinpyrazone in man.
Thrombosis research. Supplement 1983;4():145-52.
1983: J Rosenfeld; Michael Buchanan; P A Reilly; A G Turpie
Dipyridamole disposition after chronic administration: effect of aspirin.
Thrombosis research. Supplement 1983;4():137-43.
1983: Michael Buchanan
Sulfinpyrazone: relationship between dose, kinetics, plasma concentrations and biological effects.
Thrombosis research. Supplement 1983;4():89-92.
1982: Michael Buchanan; M Blajchman; J Hirsh
Inhibition of arterial thrombosis and platelet function by nafazatrom.
Thrombosis research 1982;28(2):157-70.
1982: J Rosenfeld; D Devereaux; Michael Buchanan; A G Turpie
High-performance liquid chromatographic determination of dipyridamole.
Journal of chromatography 1982;231(1):216-21.
1982: Michael Buchanan; C A Crowley; R E Rosin; M A Gimbrone; B M Babior
Studies on the interaction between GP-18-0-deficient neutrophils and vascular endothelium.
Blood 1982;60(1):160-5.
1982: Michael Buchanan; J A Rischke; J Hirsh
Aspirin inhibits platelet function independent of the acetylation of cyclo-oxygenase.
Thrombosis research 1982;25(5):363-73.
1982: M A Gimbrone; Michael Buchanan
Interactions of platelets and leukocytes with vascular endothelium: in vitro studies.
Annals of the New York Academy of Sciences 1982;401():171-83.
1981: Michael Buchanan; E Dejana; M Gent; J F Mustard; J Hirsch
Enhanced platelet accumulation onto injured carotid arteries in rabbits after aspirin treatment.
The Journal of clinical investigation 1981;67(2):503-8.
1980: Michael Buchanan; E Dejana; J P Cazenave; M Richardson; J F Mustard; J Hirsh
Differences in inhibition of PGI2 production by aspirin in rabbit artery and vein segments.
Thrombosis research 1980;20(4):447-60.
1979: Michael Buchanan; C J Carter; J Hirsch
Decreased platelet thrombogenecity in association with increased platelet turnover and vascular damage.
Blood 1979;54(6):1369-75.
1979: Michael Buchanan; M A Blajchman; E Dejana; J F Mustard; A F Senyi; J Hirsh
Shortening of the bleeding time in thrombocytopenic rabbits after exposure of jugular vein to high aspirin concentration.
Prostaglandins and medicine 1979;3(6):333-42.
1979: Michael Buchanan; J Rosenfeld; M Gent; W Lawrence; J Hirsh
Increased dipyridamole plasma concentrations associated with salicylate administration. Relationship to effects on platelet aggregation in vivo.
Thrombosis research 1979;15(5-6):813-20.
1979: Michael Buchanan; E Dejana; J P Cazenave; J F Mustard; J Hirsh
Uncontrolled PGI2 production by whole vessel wall segments due to thrombin generation in vivo and its prevention by heparin.
Thrombosis research 1979;16(3-4):551-5.
1978: Michael Buchanan; J Rosenfeld; J Hirsh
The prolonged effect of sulfinpyrazone on collagen-induced platelet aggregation in vivo.
Thrombosis research 1978;13(5):883-92.
1978: J G Kelton; J Hirsh; C J Carter; Michael Buchanan
Sex differences in the antithrombotic effects of aspirin.
Blood 1978;52(5):1073-6.
1978: J G Kelton; J Hirsh; C J Carter; Michael Buchanan
Thrombogenic effect of high-dose aspirin in rabbits. Relationship to inhibition of vessel wall synthesis of prostaglandin I2-like activity.
The Journal of clinical investigation 1978;62(4):892-5.
1978: Michael Buchanan; J Hirsh
A comparison of the effects of aspirin and dipyridamole on platelet aggregation in vivo and ex vivo.
Thrombosis research 1978;13(3):517-29.
1974: J Hirsh; J F Cade; E Regoeczi; M Gent; Michael Buchanan; D M Hynes
Resolution of experimental pulmonary emboli with heparin and streptokinase in different dosage regimens.
The Journal of clinical investigation 1974;54(4):782-91.
1974: L Jorgensen; M A Packham; H C Rowsell; Michael Buchanan; J F Mustard
Focal aortic injury caused by cannulation: increased plasma protein accumulation and thrombosis.
Acta pathologica et microbiologica Scandinavica. Section A, Pathology 1974;82(5):637-47.
1974: G N Kerrigan; Michael Buchanan; J F Cade; E Regoeczi; J Hirsh
Investigation of the mechanism of false positive 125I-labelled fibrinogen scans.
British journal of haematology 1974;26(3):469-73.
1973: H J Reimers; Michael Buchanan; J F Mustard
Survival of washed rabbit platelets in vivo.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.) 1973;142(4):1222-5.
1971: L Jorgensen; J Hirsh; M F Glynn; Michael Buchanan; J F Mustard
Effect of streptokinase therapy on experimental fibrin-rich arterial thrombi.
The American journal of pathology 1971;62(1):7-16.
1970: L Jorgensen; M F Glynn; T Hovig; EDMOND MURPHY; Michael Buchanan; J F Mustard
Renal lesions and rise in blood pressure caused by adenosine diphosphate-induced platelet aggregation in rabbits.
Laboratory investigation; a journal of technical methods and pathology 1970;23(4):347-57.
1966: M F Glynn; J F Mustard; Michael Buchanan; EDMOND MURPHY
Cigarette smoking and platelet aggregation.
Canadian Medical Association journal 1966;95(11):549-53.